会上，STAAR公司再度授予爱尔眼科“全球 ... 2006年ICL V4正式进入中国。从ICL V4到Toric ICL V4，再到EVO ICL，ICL在中国呈现迅猛发展的态势，而且ICL不仅 ...

掌上春城讯“做了ICL近视矫正术，现在感觉怎么样？”“挺好的，没有不舒服，看东西特别清楚、舒服。”这段对话发生在瑞士STAAR Surgical公司全球 ...

STAAR Surgical总裁兼首席执行官Tom Frinzi表示："在我们庆祝300万枚里程碑之际，我谨代表STAAR Surgical公司衷心感谢各位医生和医务人员以及选择ICL矫正视力的各位患者。EVO ICL引领近视矫正技术变革，优势显著，患者满意度高，必将帮助更多近视患者摆脱隐形眼镜和 ...

Co provided an update on the status of the co's submission to the FDA for approval of its Visian TICL, a toric implantable Collamer lens designed to treat both myopia and astigmatism. STAAR ...

such as the EVO/EVO + Toric ICL. “FDA’s approval of STAAR’s Visian Toric ICL in the U.S. provides an exciting treatment option for myopic patients with astigmatism in search of visual freedom.

"The Visian ICL and Toric ICL V4c with STAAR's CentraFLOW technology utilizing the KS-AquaPORT' were launched in Europe in the fourth quarter of 2011. CentraFLOW eliminates the need for the ...

STAAR Surgical Company (NASDAQ ... used monthly disposable contact lenses and glasses. She received toric EVO ICL lenses to achieve Visual Freedom and break free from contact lenses and glasses.

--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ ... but not limited to FDA requirements regarding the Visian Toric ICL and/or actions related to the FDA Warning Letter and Form FDA-483s ...

Toric ICLs were implanted into 30 eyes of 18 ... and the Visian implantable collamer lens (ICL; STAAR Surgical, Monrovia, CA, USA) have both been approved by the US Food and Drug Administration ...

David Bailey, STAAR’s president and chief executive officer, noted that the recent marketing approval for the Visian Toric ICL (TICL) in South Korea and Canada and the approval of the TICL and ...

The big ticket item on the Staar Surgical horizon would be approval from the FDA for its toric ICL, which is expected some time early this year -- it is also seeking approval in Japan for the ...